Is Creatine HCl Better Than Monohydrate?
If you want more strength and more power from a creatine supplement, plain monohydrate is still the form to buy. It's cheap, it's the version behind most of the human evidence, and it works when you pair it with hard training. Creatine hydrochloride is marketed as more soluble and better absorbed. Three recent randomized comparisons exist: two found HCl no better, and a third, a very small four-week trial in soccer players, hinted otherwise. For steady-state endurance, HCl has little direct evidence and monohydrate's benefit is mostly repeated hard surges, not VO2max or long time trials. That's a signal worth watching, not a reason to switch.
Creatine hydrochloride costs more than monohydrate and promises a smarter molecule: more soluble, better absorbed, smaller dose, less bloating. Solubility isn't the thing you care about, though. You care about whether you squat more in eight weeks. A handful of small human comparisons have tested HCl against monohydrate, including three recent randomized studies, and the balance still shows no reason to choose HCl for strength or endurance.
What monohydrate has already proven
The benchmark HCl has to beat is not vague. A 2025 meta-analysis pooling 69 randomized trials in 1,937 participants found that creatine plus resistance training beat placebo on bench or chest press, squat, vertical jump, and Wingate peak power. In adults under 50, a separate meta-analysis found larger numbers still: about 4.4 kg more upper-body strength and 11.4 kg more lower-body strength than placebo. Roughly 95% of the trials in that 69-study pool used monohydrate, which is exactly why the comparison with newer forms stays unsettled.
Two caveats ride along with those figures. Handgrip and leg press were not clearly improved in the 69-trial analysis, so the benefit is not uniform across every test. And the signal is concentrated in men and younger adults. In the pooled subgroup analyses, female participants did not show significant strength gains, and a systematic review of active females found improvement in only 3 of 11 strength and power studies. If you're a woman training hard, creatine may still be worth taking, but the expected effect is less certain than the headline numbers suggest.
The other thing monohydrate has is exposure. A 2025 safety analysis pooling hundreds of trials, with more than 12,000 participants in each arm, found similar participant-level side-effect rates: about 4.6% with creatine and 4.2% with placebo. Kidney markers did not differ in that analysis or in related controlled studies, although serum creatinine can rise because creatine turns over into creatinine. That can confuse a lab read; it is not, by itself, kidney injury. If you already have kidney disease or persistent gut symptoms, that is the place to bring a clinician in before starting.
Where the absorption claim comes from
The published evidence behind creatine HCl's absorption claim is a solubility result, not a human performance result. A separate rat pharmacokinetic paper used modeling to predict differences with HCl. That is not the same as showing better results in people. No published human trial has compared HCl and monohydrate head to head for plasma creatine, muscle uptake, or whole-body retention at matched creatine doses.
There's a deeper problem with the premise. Monohydrate's intestinal absorption is already near complete in human data: nearly all of an oral dose is either taken up by tissue or excreted in urine. You can't improve much on near-complete absorption. Making creatine dissolve faster in a glass doesn't create headroom that isn't there. Six days of 20 g/day raises muscle total creatine about 20%, and 3 g/day gets you to a similar place over about four weeks without loading. That ceiling is set by the muscle, not the powder.
Three recent trials, one open question
The newer performance comparisons are small. A 2024 randomized trial put 40 adults aged 18 to 25 through eight weeks of resistance training on either HCl at 0.03 g/kg/day, monohydrate with a loading phase, monohydrate at the same 0.03 g/kg/day without loading, or placebo. HCl added nothing over monohydrate. In 2025, a trial in 31 elite team-sport athletes compared 5 g/day of HCl, 5 g/day of monohydrate, or placebo for eight weeks and found no between-group differences; the authors called claims of HCl superiority unfounded. Only monohydrate raised the fat-free mass index in that trial.
Then, in September 2026, a trial in 40 collegiate male soccer players ran four weeks of repeated-sprint training. The creatine groups improved more than placebo on physical performance, peak power, and fatigue index, and HCl and creatine ethyl ester beat monohydrate on some sprint, jump, agility, and peak-power measures. VO2max and mean power did not differ among forms. Ten men per arm, four weeks, no replication. A result that small can turn on a handful of fast athletes landing in one group. It's the kind of finding that justifies a bigger trial, not a purchase.
| Form or claim | What human evidence shows | Takeaway for strength or endurance |
|---|---|---|
| Creatine monohydrate | Meta-analyses and position stands support better strength and high-intensity performance when paired with resistance or sport-specific training. | Default choice for strength, power, and repeated hard efforts. |
| Creatine hydrochloride | Human evidence is thin. Two recent comparisons found no advantage over monohydrate; one very small 2026 soccer trial favored HCl for some short-term sprint and power outcomes. | Not proven better. Watch the 2026 signal, but don't treat it as settled. |
| Better absorption or solubility claims | Monohydrate absorption is already near complete. | Better mixability is not proof of better performance. |
| Other alternative creatine forms | A systematic review found no consistent performance advantage for studied alternative forms, and reviews and direct comparisons have not shown a durable reason to prefer them over monohydrate. | A new form has to beat monohydrate on outcomes, not packaging. |
What this changes if you train
For strength, power, and repeated hard efforts, monohydrate at 3 to 5 g/day is the evidence-based default, and the training stimulus is the part that actually does the work. Creatine taken without resistance training is much less reliable for lean mass, and its strength effect is smaller and less consistent without that stimulus, though anaerobic power tests improve fairly consistently either way. Loading at 20 g/day for 5 to 7 days gets you saturated faster; skipping it gets you to the same place in about a month. Neither route requires the expensive version.
Endurance is a different answer. A scoping review of 38 studies found that any benefit is more likely in selected repeated high-intensity efforts than in steady-state outcomes like time trials and time to exhaustion. In one small triathlon study, athletes improved power in repeated 15-second sprints performed after 30 minutes of continuous work. The added body water can also weigh against you in running. HCl has not been tested in comparable steady-state endurance trials.
There's also a regulatory asymmetry. Creatine monohydrate is listed in FDA's GRAS inventory with a no-questions letter for specified food uses; no equivalent HCl listing was found in FDA sources. That does not mean HCl is unsafe or illegal in every product, but the regulatory record is thinner. Supplements generally are not approved by FDA for effectiveness before sale; firms are responsible for lawful, truthful labeling. Evidence still has to come from human outcome trials.
What would change this answer is straightforward, and it's the trial nobody has run: a preregistered, adequately powered comparison of HCl and monohydrate at matched creatine doses over a real training block, measuring muscle creatine retention alongside strength, repeated sprints, body composition, and gut symptoms. Until that exists, HCl is a plausible product claim with two negative recent head-to-head results and one small positive one. Monohydrate is the form with the evidence for strength and high-intensity performance.